Travere Therapeutics Inc (TVTX)
Depreciation & Amortization
$63.37M
TTM · Period ending: · USD
TVTX Depreciation & Amortization
Latest reported$63.37Mperiod ending
Latest reported$63.37Mperiod ending
TVTX TTM Depreciation & Amortization ($12.50K → $63.37M)
TTM Depreciation & Amortization
High-resolution chart · PNG
TVTX depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 63,371,000 | |
| 73,153,000 | |
| 60,743,000 | |
| 54,697,000 | |
| 50,148,000 | |
| 46,477,000 | |
| 43,555,000 | |
| 43,316,000 | |
| 43,552,000 | |
| 44,154,000 | |
| 40,894,000 | |
| 38,343,000 | |
| 33,020,000 | |
| 30,181,000 | |
| 30,653,000 | |
| 27,402,000 | |
| 29,123,000 | |
| 27,635,000 | |
| 26,617,000 | |
| 27,200,000 | |
| 25,766,000 | |
| 24,997,000 | |
| 24,579,000 | |
| 23,236,000 | |
| 22,173,000 | |
| 21,163,000 | |
| 20,408,000 | |
| 19,997,000 | |
| 19,419,000 | |
| 19,221,000 | |
| 18,668,000 | |
| 18,257,000 | |
| 18,074,000 | |
| 17,868,000 | |
| 17,804,000 | |
| 17,518,000 | |
| 16,998,000 | |
| 16,528,000 | |
| 16,135,000 | |
| 15,928,000 | |
| 15,714,000 | |
| 15,504,253 | |
| 13,392,000 | |
| 11,275,229 | |
| 9,244,432 | |
| 7,052,598 | |
| 5,401,038 | |
| 3,599,674 | |
| 1,803,292 | |
| 291,012 | |
| 215,993 | |
| 210,596 | |
| 192,497 | |
| 139,358 | |
| 87,190 | |
| 35,722 | |
| 0 | |
| 0 | |
| 5,207 | |
| 5,207 | |
| 5,207 | |
| 8,333 | |
| 12,500 | |
| 15,626 | |
| 15,626 |